Haemonetics Corp (HAE)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$82.07
Buy
$84.50
$-0.96 (-1.14%)
Prices updated at 12 Dec 2025, 21:18 EST
| Prices minimum 15 mins delay
Prices in USD
Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2025 | 55.04 |
| 2024 | 52.83 |
| 2023 | 52.63 |
| 2022 | 50.90 |
| 2021 | 45.70 |
| 2020 | 49.02 |
| 2019 | 43.15 |
| 2018 | 45.57 |
| 2017 | 42.71 |
| 2016 | 44.66 |
| 2015 | 47.72 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 3.08 |
| 2024 | 2.95 |
| 2023 | 3.54 |
| 2022 | 3.74 |
| 2021 | 2.92 |
| 2020 | 6.75 |
| 2019 | 6.09 |
| 2018 | 5.73 |
| 2017 | 3.40 |
| 2016 | 2.26 |
| 2015 | 1.88 |
Price/Forward earnings (YTD)
15.31
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2025 | 7.22 |
| 2024 | 5.69 |
| 2023 | 6.08 |
| 2022 | 2.36 |
| 2021 | 5.15 |
| 2020 | 6.02 |
| 2019 | 4.38 |
| 2018 | 3.68 |
| 2017 | -2.05 |
| 2016 | -3.96 |
| 2015 | 1.13 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2025 | 2.99 |
| 2024 | 2.29 |
| 2023 | 2.37 |
| 2022 | 2.48 |
| 2021 | 2.49 |
| 2020 | 2.16 |
| 2019 | 1.91 |
| 2018 | 1.64 |
| 2017 | 1.67 |
| 2016 | 1.83 |
| 2015 | 1.80 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
